Prosecution Insights
Last updated: April 19, 2026

Seres Therapeutics Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
3
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18583667 COMPOSITIONS AND METHODS DEVI, SARVAMANGALA 1645 Final Rejection Feb 21, 2024
18532577 MANIPULATION OF TRYPTAMINE METABOLISM AFREMOVA, VERA 1653 Final Rejection Dec 07, 2023
17311262 COMPOSITIONS FOR STABILIZING BACTERIA AND USES THEREOF MARTIN, RACHEL E 1657 Final Rejection Jun 04, 2021

Managing Seres Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month